Stat bite: Medicaid coverage of tobacco-dependence treatments.
D000279:Administration, Cutaneous; D000281:Administration, Intranasal; D000284:Administration, Oral; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000191:economics; D001552:Benzazepines / Q000008:administration & dosage / Q000191:economics; D016642:Bupropion / Q000008:administration & dosage / Q000191:economics; D003376:Counseling / Q000379:methods; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage / Q000191:economics; D005260:Female; D006801:Humans; D019458:Insurance Coverage; D008297:Male; D008484:Medicaid; D009538:Nicotine / Q000008:administration & dosage / Q000191:economics; D018722:Nicotinic Agonists / Q000008:administration & dosage / Q000191:economics; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy; D011810:Quinoxalines / Q000008:administration & dosage / Q000191:economics; D014029:Tobacco Use Disorder / Q000188:drug therapy / Q000191:economics* / Q000628:therapy*; D014481:United States; D000068580:Varenicline
D018687:Antidepressive Agents, Second-Generation; D001552:Benzazepines; D018765:Dopamine Uptake Inhibitors; D018722:Nicotinic Agonists; D011810:Quinoxalines; D016642:Bupropion; D009538:Nicotine; D000068580:Varenicline